Michael R Burgess - Bristol-Myers Squibb

基本信息

浏览量：113

职业迁徙

个人简介

Immuno-oncology and Cell Therapy

研究兴趣

论文共 70 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Phase 1 Clinical Trial of B-Cell Maturation Antigen (BCMA) NEX-T® Chimeric Antigen Receptor (CAR) T Cell Therapy CC-98633/BMS-986354 in Participants with Triple-Class Exposed Multiple Myeloma

Gayathri Ravi,Shambavi Richard,Shaji Kumar,Shebli Atrash,Michaela Liedtke,Gurbakhash Kaur,Benjamin Derman,P. Leif Bergsagel,Sham Mailankody,Philip McCarthy,Alok Shrestha, Lisa M. Kelly,Thomas Ly,Sharmila Das,Jerill Thorpe, Alison Maier, Divya Varun, Garnet Navarro,Michael R. Burgess,Kristen Hege, Ashley K. Koegel,Luciano J. Costa

Leukemia（2025）

引用0浏览0WOSNATURE引用

OA-08 Safety and Preliminary Efficacy of BMS-986393, a GPRC5D CAR T Cell Therapy, in Patients (pts) with Relapsed/Refractory (RR) Multiple Myeloma (MM) and 1–3 Prior Regimens: Results from a Phase 1 Study

Myo Htut,Omar Nadeem,Jesus Berdeja,Larry Anderson,Adriana Rossi,Tara Gregory,Thomas Martin,Luciano Costa, Hongxiang Hu, Chaoqun Mei,Alok Shrestha,Safiyyah Ziyad, Wei-Ming Kao, Allison Kaeding,Michael Burgess,Susan Bal

Clinical Lymphoma Myeloma and Leukemia (2024): S5-S6

引用0浏览0引用

Informing the Recommended Phase III Dose of Alnuctamab, a CD3 × BCMA T‐Cell Engager, Using Population Pharmacokinetics and Exposure–Response Analysis

Brian Kiesel,Mayu Osawa,Madhan Masilamani, Merav Bar,Kevin Hsu,Colin Godwin,Michael Burgess,Manisha Lamba,Allison Gaudy

CLINICAL PHARMACOLOGY & THERAPEUTICSno. 3 (2024): 866-874

引用0浏览0WOS引用

Safety and Preliminary Efficacy of BMS-986393, a GPRC5D CAR T Cell Therapy, in Patients (pts) with Relapsed/Refractory (RR) Multiple Myeloma (MM) and 1-3 Prior Regimens: Results from a Phase 1 Study

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2024): S5-S6

引用0浏览0引用

BMS-986393, a G Protein-Coupled Receptor Class C Group 5 Member D (Gprc5d)-Targeted CAR T Cell Therapy, in Patients (pts) with Relapsed/Refractory (RR) Multiple Myeloma (MM) and 1-3 Prior Regimens: Updated Phase 1 Safety and Efficacy Results

Susan Bal,Myo Htut,Jesús G. Berdeja,Larry D Anderson,Adriana Rossi,Tara Gregory,Thomas G Martin,Luciano J. Costa, Hongxiang Hu,Jinjie Chen, Chaoqun Mei, Naomey Sarkis,Alok Shrestha,Safiyyah Ziyad, Wei-Ming Kao,Allison J Kaeding,Michael R. Burgess,Omar Nadeem

Bloodno. Supplement 1 (2024): 2069-2069

引用0浏览0引用

S193: BMS-986393 (CC-95266), A G PROTEIN–COUPLED RECEPTOR CLASS C GROUP 5 MEMBER D (GPRC5D)–TARGETED CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1 STUDY

Susan Bal,Jesus Berdeja,Myo Htut,Mehmet Kocoglu,Tara Gregory,Larry D. Anderson,Adriana Rossi,Daniel Egan,Luciano Costa, Lisa Kelly,Safiyyah Ziyad, Hongxiang Hu,Yanping Chen,Allison J. Kaeding,Michael Burgess,Kristen Hege,Omar Nadeem

HemaSphere（2023）

引用3浏览0引用

P825: SOLUBLE FACTORS CORRELATED WITH CYTOKINE RELEASE SYNDROME (CRS) WITH IV VS SUBCUTANEOUS (SC) ALNUCTAMAB (ALNUC; BMS-986349; CC-93269) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

Isaac Boss,Ethan Thompson,Allison Gaudy, Thi Minh Diem Vu,Colin Godwin,Michael Burgess,Sandy W. Wong,Luciano Costa

HemaSphere (2023)

引用0浏览0引用

BMS-986393 (CC-95266), a G Protein-Coupled Receptor Class C Group 5 Member D (Gprc5d)-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from a Phase 1 Study

Omar Nadeem,Jesus Berdeja,Myo Htut,M. Hakan Kocoglu,Tara Gregory,Larry Anderson,Adriana Rossi,Daniel Egan,Luciano Costa, Lisa Kelly,Safiyyah Ziyad, Hongxiang Hu,Yanping Chen, Allison Kaeding,Michael Burgess,Susan Bal

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）

引用14浏览0引用

P-037 BMS-986393 (CC-95266), a G Protein-Coupled Receptor Class C Group 5 Member D (Gprc5d)-Targeted CAR T-cell Therapy for Relapsed/refractory Multiple Myeloma (RRMM): Results from a Phase 1 Study

Omar Nadeem,Jesus Berdeja,Myo Htut,M Hakan Kocoglu,Tara Gregory,Larry Anderson,Adriana Rossi,Daniel Egan,Luciano Costa, Lisa Kelly,Safiyyah Ziyad, Hongxiang Hu,Yanping Chen, Allison Kaeding,Michael Burgess,Susan Bal

Clinical Lymphoma Myeloma and Leukemia（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn